Rare Disease Therapies Advance for Dravet Syndrome and Spinal Muscular Atrophy
New treatments for rare pediatric neurological conditions show promise, with zorevunersen reducing seizures in Dravet syndrome patients and an SMA therapy under FDA review following stem cell research breakthroughs.